摘要
目的探讨布地奈德联合沙丁胺醇雾化吸入治疗支气管哮喘急性发作的临床疗效。方法选取88例支气管哮喘急性发作患者,分为观察组与对照组,各44例,分别给予布地奈德联合沙丁胺醇雾化吸入治疗、沙丁胺醇雾化吸入治疗,比较两组临床疗效及肺功能指标。结果治疗后,观察组与对照组患者总有效率比较(90.9%对79.5%),差异有统计学意义(P<0.05);与治疗前比较,两组患者治疗后肺功能指标明显升高(P<0.05),且观察组明显优于对照组(P<0.05)。结论布地奈德联合沙丁胺醇雾化吸入在治疗支气管哮喘急性发作中具有重要作用。
Objective To investigate the clinical effect of budesonide combined with salbutamol atomization inhalation in treatment of acute attack of bronchial asthma.Methods Selected 88 cases of acute attack of bronchial asthma patients,divided into the observation group and control group,each 44 cases,were given budesonide combined with salbutamol atomization inhalation treatment,salbutamol atomization inhalation treatment,compared two groups of clinical curative effect and lung function index.Results After treatment,two groups of patients with total effective rate（90.9%vs79.5%）,the difference was statistically significant（P 0.05）;compared with before treatment, pulmonary function index increased significantly in the two groups after treatment（P〈0.05）,patients in observation group were significantly better than the control group（P〈0.05）.Conclusion Joint salbutamol aerosol inhalation budesonide in treating bronchial asthma with acute plays an important role.
出处
《中国药物经济学》
2015年第2期39-41,共3页
China Journal of Pharmaceutical Economics
